JP3395367B2 - Liquid colorant - Google Patents
Liquid colorantInfo
- Publication number
- JP3395367B2 JP3395367B2 JP14852694A JP14852694A JP3395367B2 JP 3395367 B2 JP3395367 B2 JP 3395367B2 JP 14852694 A JP14852694 A JP 14852694A JP 14852694 A JP14852694 A JP 14852694A JP 3395367 B2 JP3395367 B2 JP 3395367B2
- Authority
- JP
- Japan
- Prior art keywords
- iron oxide
- colorant
- black iron
- microcapsules
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003086 colorant Substances 0.000 title claims description 23
- 239000007788 liquid Substances 0.000 title description 11
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 19
- 239000003638 chemical reducing agent Substances 0.000 claims description 16
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 claims description 16
- 239000003094 microcapsule Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 description 9
- 239000011553 magnetic fluid Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 6
- 239000011668 ascorbic acid Substances 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- -1 alkali metal salts Chemical class 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000013268 sustained release Methods 0.000 description 4
- 239000012730 sustained-release form Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 238000012695 Interfacial polymerization Methods 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- ZZPKZRHERLGEKA-UHFFFAOYSA-N resorcinol monoacetate Chemical compound CC(=O)OC1=CC=CC(O)=C1 ZZPKZRHERLGEKA-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】
【0001】
【産業上の利用分野】本発明は、液状着色剤に関する。
更に詳しくは、化粧料等に有効に用いられる液状着色剤
に関する。
【0002】
【従来の技術】黒色酸化鉄色剤として磁性流体を用いた
メーキャップ化粧料が知られている(特開平1-242513号
公報)。特に、従来からアイラインなどに使用されてい
たカーボンの一種から発がん性物質である3,4-ベンツピ
レンが発見され、その代替材料として水ベース磁性流体
が最近注目されている。この水ベース磁性流体を用いた
ものは、黒くて伸びが良く、紫外線の吸収効果もあるた
め、メーキャップ化粧料として人気を集めている。
【0003】しかしながら、黒色酸化鉄色剤が磁性流体
であれあるいは市販の分散タイプ超微粒子黒色酸化鉄で
あれ、黒色酸化鉄は一般に空気中の酸素で酸化されて、
経時的に赤色酸化鉄に変化する性質を有しているため、
そこに還元性物質を共存させておくことが提案されてい
る(特開平3-7213号公報)。
【0004】しかるに、黒色酸化鉄色剤および溶剤を含
有する液状着色材に、単に還元性物質を共存させただけ
では、黒色酸化鉄の表面も還元され、その表面の色は初
期の色よりも更に黒くなってしまうという不具合が生ず
る。逆に、還元が行われた状態を初期色とすることもで
きるが、この場合には経時的な酸化が起こり、還元性物
質を用いなかった場合と同様の変色が起こるのを避ける
ことができない。
【0005】
【発明が解決しようとする課題】本発明の目的は、黒色
酸化鉄色剤、還元性物質および溶剤を含有する液状着色
剤において、黒色着色剤としての経時的安定性を付与せ
しめたものを提供することにある。
【0006】
【課題を解決するための手段】かかる本発明の目的は、
上記液状着色剤において、還元性物質をマイクロカプセ
ル中に封入した状態で用いることにより達成される。
【0007】黒色酸化鉄色剤としては、液状着色剤の用
途が化粧料などの場合、水ベース磁性流体が好んで用い
られる。水ベース磁性流体としては、第1鉄塩-第2鉄塩
混合物水溶液にNaOH水溶液またはNH3水溶液等を添加し
てマグネタイトを製造する湿式法マグネタイト磁性流体
が一般に用いられる。磁性流体以外にも、酸化鉄が黒色
を示す限り、市販の分散タイプ超微粒子酸化鉄を使用す
ることができ、その粒径は細かい方が好ましい。
【0008】溶剤としては、液状着色剤の他の用途、例
えば顔料、塗料、印刷などの各種用途に応じて、水以外
にも各種の有機溶剤、例えばアルコール類、ポリオール
類、ケトン類、エーテル類、脂肪族、脂環式または芳香
族の炭化水素類、スクアレン、ヒマシ油、綿実油、液状
ラノリン、流動パラフィン等を用いることができる。黒
色酸化鉄色剤は、これらの溶剤中に約2〜55重量%、好ま
しくは17〜51重量%を占めるような割合で添加されて用
いられる。
【0009】また、還元剤としては、(1)チオ硫酸、亜
硫酸、重亜硫酸、ピロ亜硫酸、次亜リン酸等の無機酸の
アルカリ金属塩、(2)バニリン、オイゲノール、イソオ
イゲノール、没食子酸またはそのアルキルエステル、
(3)ハイドロキノン、カテコール、レゾルシン、酢酸レ
ゾルシン、ブチル化ヒドロキシアニソール等の水酸基含
有芳香族化合物、(4)ピリドキシン、ピリドキサール、
リン酸ピリドキサール等の水酸基含有複素環化合物、
(5)ぶどう糖、乳糖、果糖等のヘミアセタール性水酸基
含有糖、(6)アスコルビン酸、クエン酸、こうじ酸、ソ
ルビン酸等の有機酸またはそのアルカリ金属塩などの少
なくとも一種が、黒色酸化鉄色剤の溶剤溶液量に対して
約0.1〜10重量%、好ましくは約0.4〜4重量%の割合で用
いられる。
【0010】これらの還元剤は、マイクロカプセル中に
封入された状態で用いられる。還元剤のマイクロカプセ
ル中への封入は、任意の方法で行うことができ、例えば
界面重合法、in situ重合法、液中硬化被覆法、コアセ
ルベーション法、スプレードライング法、無機質壁法な
どによって行われる。このようなマイクロカプセル化に
よって、還元剤は徐放性を示すようになるが、その徐放
速度を調節するために先に本出願人によって提案された
方法、即ち、被徐放物質およびポリエチレンイミンを溶
解させた水溶液をジイソシアネート溶液中に添加して被
徐放物質の水溶液を内包させたマイクロカプセルを界面
重合法によって形成させた後、この被徐放物質水溶液内
包マイクロカプセルを更に被徐放物質水溶液中で加熱処
理することも有効である(特公平6-9650号公報)。
【0011】組成物の調製は、黒色酸化鉄の溶剤溶液に
還元性物質封入マイクロカプセルを添加することにより
行われる。黒色酸化鉄が水溶液(水分散液)として用いら
れる場合には、界面活性剤以外に1,3-ブチレングリコー
ル等が湿潤剤として水溶液に添加されて用いられる。
【0012】
【発明の効果】黒色酸化鉄色剤、還元性物質および溶剤
を含有する液状着色剤において、還元性物質をマイクロ
カプセル中に封入し、徐放性還元性物質として用いるこ
とにより、液状着色剤の色の経時的な変化を有効に防止
することができる。
【0013】
【実施例】次に、実施例について本発明を説明する。
【0014】実施例
エチルセルロースを加熱シクロヘキサン中に加え、溶解
させた後、このシクロヘキサン溶液中に相分離剤として
のポリイソブチレンおよび還元剤としてのアスコルビン
酸を加え、撹拌しながら冷却して、アスコルビン酸封入
マイクロカプセル(粒径約200μm、アスコルビン酸含量
約90%)を得た。
【0015】このアスコルビン酸封入マイクロカプセル
を、黒色酸化鉄(平均径10nmの球形マグネタイト)20重量
%、ドデシルベンゼンスルホン酸ナトリウム3重量%、1,3
-ブチレングリコール5重量%および純水72重量%よりなる
黒色酸化鉄色剤溶液に、この溶液量に対してアスコルビ
ン酸量が5重量%となる割合で加えて、水性着色剤を調製
した。
【0016】調製された水性着色剤を、中綿入りペンに
含浸させ、52℃の恒温槽中に4週間放置した後、紙に文
字を描いたが、その色は初期色と殆んど変わらず、変色
は認められなかった。
【0017】比較例
実施例において、マイクロカプセルに封入されないアス
コルビン酸が用いられた。52℃に4週間放置された後の
水性着色剤によって描かれた文字の色は、初期色よりも
かなり赤味がかっていた。Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a liquid colorant.
More specifically, the present invention relates to a liquid colorant effectively used in cosmetics and the like. 2. Description of the Related Art A makeup cosmetic using a magnetic fluid as a black iron oxide coloring agent is known (Japanese Patent Laid-Open No. 1-242513). In particular, a carcinogenic substance, 3,4-benzpyrene, has been discovered from a type of carbon conventionally used for eye lines and the like, and a water-based magnetic fluid has recently been receiving attention as an alternative material. The one using this water-based magnetic fluid has been popular as a makeup cosmetic because it is black, has good elongation, and has an effect of absorbing ultraviolet rays. [0003] However, whether the black iron oxide coloring agent is a magnetic fluid or a commercially available dispersed type ultrafine black iron oxide, the black iron oxide is generally oxidized by oxygen in the air,
Because it has the property of changing to red iron oxide over time,
It has been proposed to allow a reducing substance to coexist there (JP-A-3-7213). However, simply adding a reducing substance to a liquid coloring material containing a black iron oxide coloring agent and a solvent also reduces the surface of the black iron oxide, and the color of the surface is higher than the initial color. Further, a problem of blackening occurs. Conversely, the state in which the reduction is performed can be used as the initial color, but in this case, oxidation occurs over time, and it is unavoidable that the same discoloration as when no reducing substance is used occurs. . SUMMARY OF THE INVENTION An object of the present invention is to provide a liquid colorant containing a black iron oxide colorant, a reducing substance, and a solvent, to give the black colorant stability over time. Is to provide things. SUMMARY OF THE INVENTION The object of the present invention is as follows.
This is achieved by using the liquid colorant in a state where a reducing substance is encapsulated in microcapsules. As the black iron oxide colorant, when the application of the liquid colorant is a cosmetic or the like, a water-based magnetic fluid is preferably used. As the water-based magnetic fluid, a wet-process magnetite magnetic fluid for producing magnetite by adding an aqueous solution of NaOH or an aqueous solution of NH 3 to an aqueous solution of a mixture of a ferrous salt and a ferric salt is generally used. In addition to the magnetic fluid, as long as the iron oxide shows black, commercially available ultrafine iron oxide particles of a dispersion type can be used, and the smaller the particle size, the more preferable. Examples of the solvent include various organic solvents other than water, such as alcohols, polyols, ketones, and ethers, depending on other uses of the liquid colorant, for example, various uses such as pigments, paints, and printing. , Aliphatic, alicyclic or aromatic hydrocarbons, squalene, castor oil, cottonseed oil, liquid lanolin, liquid paraffin, and the like. The black iron oxide coloring agent is used by being added to these solvents at a ratio of about 2 to 55% by weight, preferably 17 to 51% by weight. Examples of the reducing agent include (1) alkali metal salts of inorganic acids such as thiosulfuric acid, sulfurous acid, bisulfite, pyrosulfite, and hypophosphorous acid; (2) vanillin, eugenol, isoeugenol, gallic acid and the like. Its alkyl esters,
(3) hydroquinone, catechol, resorcin, resorcin acetate, hydroxyl-containing aromatic compounds such as butylated hydroxyanisole, (4) pyridoxine, pyridoxal,
A hydroxyl group-containing heterocyclic compound such as pyridoxal phosphate,
(5) glucose, lactose, hemiacetal hydroxyl-containing sugars such as fructose, (6) at least one of organic acids such as ascorbic acid, citric acid, kojic acid, sorbic acid or alkali metal salts thereof, black iron oxide color It is used in a proportion of about 0.1 to 10% by weight, preferably about 0.4 to 4% by weight, based on the amount of the solvent solution of the agent. [0010] These reducing agents are used in a state of being encapsulated in microcapsules. The encapsulation of the reducing agent in the microcapsules can be performed by any method, for example, by an interfacial polymerization method, an in situ polymerization method, a liquid curing coating method, a coacervation method, a spray drying method, an inorganic wall method, or the like. Done. Such microencapsulation makes the reducing agent exhibit a sustained release property, but the method proposed by the present applicant for controlling the sustained release rate, that is, a sustained release substance and polyethyleneimine Is added to the diisocyanate solution to form microcapsules containing an aqueous solution of the controlled release substance by an interfacial polymerization method. Heat treatment in an aqueous solution is also effective (Japanese Patent Publication No. 6-9650). The preparation of the composition is carried out by adding microcapsules encapsulating a reducing substance to a solvent solution of black iron oxide. When black iron oxide is used as an aqueous solution (aqueous dispersion), 1,3-butylene glycol or the like is added to the aqueous solution as a wetting agent in addition to the surfactant. According to the present invention, in a liquid colorant containing a black iron oxide colorant, a reducing substance and a solvent, the reducing substance is encapsulated in microcapsules and used as a sustained-release reducing substance. It is possible to effectively prevent the color of the colorant from changing over time. Next, the present invention will be described by way of examples. Example 1 After ethyl cellulose was added to and dissolved in heated cyclohexane, polyisobutylene as a phase separating agent and ascorbic acid as a reducing agent were added to the cyclohexane solution, and the mixture was cooled while stirring and sealed with ascorbic acid. Microcapsules (particle size: about 200 μm, ascorbic acid content: about 90%) were obtained. The ascorbic acid-encapsulated microcapsules were mixed with black iron oxide (spherical magnetite having an average diameter of 10 nm) of 20 weight
%, Sodium dodecylbenzenesulfonate 3% by weight, 1,3
-An aqueous colorant was prepared by adding 5% by weight of butylene glycol and 72% by weight of pure water to a black iron oxide colorant solution such that the amount of ascorbic acid was 5% by weight based on the amount of the solution. The prepared aqueous colorant was impregnated into a pen containing batting and left in a constant temperature bath at 52 ° C. for 4 weeks, after which letters were drawn on paper, but the color was almost unchanged from the initial color. No discoloration was observed. Comparative Example In the examples, ascorbic acid not encapsulated in microcapsules was used. After standing at 52 ° C. for 4 weeks, the color of the letters drawn by the aqueous colorant was considerably redder than the initial color.
フロントページの続き (56)参考文献 特開 平3−7213(JP,A) 特開 平7−96166(JP,A) 特開 平2−88514(JP,A) 特開 平7−324015(JP,A) 特開 平4−74116(JP,A) 特開 昭53−75341(JP,A) 特公 平6−9650(JP,B2) 特表 平2−503000(JP,A) 国際公開91/1801(WO,A1) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/032 Continuation of front page (56) References JP-A-3-7213 (JP, A) JP-A-7-96166 (JP, A) JP-A-2-88514 (JP, A) JP-A-7-324015 (JP) JP-A-4-74116 (JP, A) JP-A-53-75341 (JP, A) JP-B-6-9650 (JP, B2) JP-T-2-503000 (JP, A) International publication 91 / 1801 (WO, A1) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 7/ 00-7/032
Claims (1)
を含有する着色剤において、還元性物質がマイクロカプ
セル中に封入されて用いられている液状着色剤。(1) A colorant containing a black iron oxide coloring agent, a reducing substance and a solvent, wherein the reducing substance is used by being encapsulated in microcapsules. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14852694A JP3395367B2 (en) | 1994-06-07 | 1994-06-07 | Liquid colorant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14852694A JP3395367B2 (en) | 1994-06-07 | 1994-06-07 | Liquid colorant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07330550A JPH07330550A (en) | 1995-12-19 |
| JP3395367B2 true JP3395367B2 (en) | 2003-04-14 |
Family
ID=15454758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14852694A Expired - Fee Related JP3395367B2 (en) | 1994-06-07 | 1994-06-07 | Liquid colorant |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3395367B2 (en) |
-
1994
- 1994-06-07 JP JP14852694A patent/JP3395367B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07330550A (en) | 1995-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100296380B1 (en) | Pigmentary granules production method and cosmetic material containing the particulates | |
| CA1270760A (en) | Process for treating dosage forms | |
| JP6242561B2 (en) | Pigment | |
| CA2406008A1 (en) | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | |
| WO2004081222A2 (en) | Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same | |
| EP0254447B1 (en) | Process for producing polymer-thickened oil macrocapsules | |
| JP3347140B2 (en) | Microcapsule containing dye, ultraviolet absorber, and antioxidant, and method for producing the microcapsule | |
| JPH10231367A5 (en) | ||
| JPH07103324B2 (en) | Small flaky substrate | |
| CN110433741B (en) | Aromatic antibacterial microcapsule with carbon skeleton and preparation method thereof | |
| EP0868396B1 (en) | Solid peroxo compounds and peroxy compounds stabilised by coating | |
| CN106070204A (en) | A kind of pesticide micro capsule slow releasing agent and preparation method thereof | |
| JPH0416212B2 (en) | ||
| JPH05261275A (en) | Formulation | |
| JP3395367B2 (en) | Liquid colorant | |
| EP1515682B1 (en) | Biliquid foam entrapment | |
| KR101880447B1 (en) | Physiologically active material complex, manufacturing method thereof and cosmetic composition using the same | |
| JP2813547B2 (en) | Functional powders for cosmetics | |
| JP3643599B2 (en) | Granule type leuco vat dye preparation | |
| JP4776811B2 (en) | Antibacterial external gel composition | |
| JPH0244016A (en) | Stabilized granular hydrogen peroxide adduct and manufacture thereof and oxidation hairdye | |
| JPH0367737B2 (en) | ||
| JP4266404B2 (en) | Powder for preparation of quick-dissolving poorly soluble drugs and its production method | |
| JP2797412B2 (en) | Liquid cosmetics | |
| JP2994781B2 (en) | Colloidal titanium oxide-adsorbed silk pigment and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |